LEVALTA
Live / Registered — Registered (as of 17 Dec 2024)
What this means for you
Registered since 17 Dec 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90669891
- Registration number
- 7602935
- Mark type
- Stylized text
- Filed
- 25 Apr 2021
- Published for opposition
- 29 Oct 2024
- Registered
- 17 Dec 2024
- Attorney of record
- Jeremy Blackowicz
Goods and services
- Class 003 — Cosmetics and cleaning preparations: Non-medicated preparations for the skin, namely, moisturizers, creams, body powders, gels, shampoos, sprays, and body washes; Non-medicated dental rinses for oral health
- Class 005 — Pharmaceuticals: Topical antibiotics to treat atopic dermatitis, actinic keratosis, acne, rosacea, psoriasis, athlete's foot, nail fungus and other skin ailments, conditions and dermatoses; Pharmaceutical preparations and substances for diagnosis and treatment of oral disease, namely, periodontitis, oral mucousitis and bone and soft tissue regeneration; Medicated dental rinse for oral health; Medicated pharmaceutical preparations and substances for the treatment and prevention of gastrointestinal diseases and disorders in humans including constipation, hepatic encephalopathy, irritable bowel syndrome, opioid induced constipation and ulcerative colitis; Medicated beverages, powders, and gels for colonoscopies and endoscopic procedures; Pharmaceutical preparations and substances to prevent and treat diabetes mellitus, epilepsy, migraines, anxiety and depression, chronic pain, headaches, psychiatric disorders, and rare diseases in the nature of Wilson and Huntington's disease, diabetes mellitus, cardiovascular/angina, hyperammonaemia, hormone deficiencies (endocrinology), cancer, otolaryngology, and urinary tract, lungs, heart infections and diseases, central nervous system disorders, neuromuscular conditions, vaginal disorders; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations and substances for the treatment of skin and nail conditions, namely, acne, psoriasis, onychomycosis, tinea pedis, actinic keratosis, rosacea and other dermatoses, fungal infections; Vitamins and mineral supplements; Non-medicated dermatologic substances and preparations for the skin, namely, ointments to treat atopic dermatitis, actinic keratosis, acne, rosacea, psoriasis, athlete's foot, nail fungus and other skin ailments, conditions and dermatoses; Non-medicated oral health substances preparations in the form of tooth and mouth powders, creams, and rinses for the treatment of periodontitis, mouth dryness, cold sores, mouth ulcers; Cotton swabs impregnated with non-medicated dermatologic skin care preparations for treating atopic dermatitis, actinic keratosis, acne, rosacea, psoriasis, athlete's foot, nail fungus and other skin ailments, conditions and dermatoses
- Class 010 — Medical apparatus: Radio frequency medical devices for contracting skin, body sculpting, and soft tissue reconstruction in a non-invasive manner; Medical devices for aesthetic and therapeutic applications for the skin and its subcutaneous structures, namely, a device for delivering energy to the skin and its underlying tissues; Lasers and radio frequency devices for medical and aesthetic treatment; Medical devices, namely, medical instruments designed for the non-invasive removal of human body fat using an external energy source
Owner
- Bausch Health Ireland Limited, DUBLIN, IE
- Bausch Health Ireland Limited, DUBLIN, IE
- Bausch Health Ireland Limited, DUBLIN, IE
Prosecution history
- 18 Feb 2026 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 11 Feb 2026 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 17 Dec 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 17 Dec 2024 — REGISTERED-PRINCIPAL REGISTER
- 29 Oct 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 29 Oct 2024 — PUBLISHED FOR OPPOSITION
- 09 Oct 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 04 Sept 2024 — CASE RETURNED TO EXAMINATION
- 04 Sept 2024 — NOTICE OF ALLOWANCE CANCELLED
- 04 Sept 2024 — PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
- 19 Aug 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 19 Aug 2024 — SOU EXTENSION 2 GRANTED
- 19 Aug 2024 — SOU EXTENSION 2 FILED
- 19 Aug 2024 — SOU TEAS EXTENSION RECEIVED
- 13 Aug 2024 — ASSIGNED TO PETITION STAFF